Adam J. Fein, Ph.D., president of Drug Channels Institute (DCI) and the author of Drug Channels, invites you to join him for DCI’s new live video webinar:
This post describes the event and explains how to purchase a registration. (Or, just click here to order.) The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia.
This event is part of The Drug Channels 2024 Video Webinar Series. (Please note that our December 2024 webinar is *not* included with next year’s 2025 Video Webinar Series.)
WHAT YOU WILL LEARN
Join Dr. Fein as he helps you and your team get ready for 2025 by outlining key issues and uncertainties that will surely affect your planning. This event can be both a capstone of your annual learning and a touchpoint for the future. DCI’s Outlook webinars have proven to be reliable and informative guides to crucial aspects of the ever-evolving healthcare industry.
During the event, Dr. Fein will share his latest thinking and projections on a wide range of topics, including:
- Latest predictions for the Inflation Reduction Act
- Expectations for the Medicare Part D market in 2025 and beyond
- Update on 340B Drug Pricing Program’s controversies
- Impact of the new Trump administration and Congress on the drug channel
- Vertical integration and consolidation trends—and prospects for dis-integration and de-consolidation
- The state of biosimilar markets
- What’s next for PBMs’ private label products and GPOs
- Retail pharmacy’s future
- Prospects for direct-to-patient channels
- What’s ahead for discount cards and cash-pay pharmacies
- The outlook for state and federal legislation on PBMs and the drug channel
- Gross-to-net bubble developments
- And much more!
PLUS: During the webinar, Dr. Fein will give participants an opportunity to unmute themselves and ask live questions. The webinar will last at least 90 minutes to accommodate audience questions.
As always, Dr. Fein will clearly distinguish his opinions and interpretations from the objective facts and data. He will draw from exclusive information found in DCI’s economic reports .
Read on for full details on pricing and registration.
